In a decision that will offer relief to patients suffering from Johnson & Johnson’s faulty hip implants, the drug regulator has asked the global health major to pay Rs 20 lakh as interim compensation to all those affected in keeping with the government-appointed committee’s recommendation.
In a decision that will offer relief to patients suffering from Johnson & Johnson’s faulty hip implants, the drug regulator has asked the global health major to pay Rs 20 lakh as interim compensation to all those affected in keeping with the government-appointed committee’s recommendation.
39.jpeg)
101.jpeg)
417.jpeg)
10.jpeg)
40.jpeg)
100.jpeg)
416.jpeg)
5.jpeg)
4.jpeg)
